Another important safety consideration is the quality of the Epitalon used
In humans 200 mg/day of orally applied lactoferrin in combination with erythropoietin normalized the hemoglobin concentration in 75 cancer patients with anemia of chronic disease (Macci et al., 2010)
Natural Pulsatile Release GHRH Pathway Support 5mg Optimal Dosing Daily Administration Available Dosage A therapeutic dosage designed to support natural growth hormone production through GHRH pathway stimulation
doi: 10.1371/journal.pbio.1000479

The GLOW Blend's comprehensive effects on skin biology make it a valuable research tool for investigating dermal regeneration, photoaging mechanisms, and the molecular basis of age-related skin changes. Chronologically aged skin exhibits characteristic features including reduced collagen density (declining 1.0-1.5% annually from early adulthood), decreased fibroblast activity, compromised barrier function, and diminished regenerative capacity, with research demonstrating that collapsed senescent fibroblasts produce low collagen while generating high levels of matrix metalloproteinases that degrade existing ECM. The GLOW Blend addresses these multifaceted aging processes through coordinated mechanisms: GHK-Cu resets aged gene expression patterns to match younger profiles while stimulating fibroblast synthetic activity, BPC-157 enhances cellular migration and proliferation essential for tissue renewal, and TB-500 restores cytoskeletal dynamics that enable efficient cellular responses to regenerative signals. Laboratory investigations demonstrate that GHK-Cu application significantly increases skin thickness, improves hydration, and stimulates collagen synthesis in experimental tissue models, with 70% of subjects showing improved collagen production compared to 50% with vitamin C and 40% with retinoic acid in controlled studies

The dePaul symptom questionnaire-2: A validation study